Autolus Therapeutics (AUTL) Stock: Buy, Sell, or Hold?
AUTL - Autolus Therapeutics plc American Depositary Share
$1.94
0.00 (0.00%)
▲
5d:
+0.0%
30d:
-21.14%
90d:
+30.2%
WAIT
LOW Confidence
Analysis Updated: Sep 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When AUTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AUTL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AUTL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AUTL is currently trading at $1.94, which is considered oversold relative to its 30-day fair value range of $2.00 to $2.39.
Technical Outlook: Technically, AUTL is in a strong uptrend. Immediate support is located at $1.83, while resistance sits at $2.23.
Market Sentiment: AUTL scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.72 (+349.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AUTL is in a strong uptrend. Immediate support is located at $1.83, while resistance sits at $2.23.
Market Sentiment: AUTL scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.72 (+349.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.00 -
$2.39
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 349.7% below Wall St target ($8.72)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.00 -
$2.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.84
Resistance Level
$2.23
Current Trend
Strong Uptrend
Technical data as of
Sep 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.10
Wall Street Target
$8.73
(+349.7%)
Revenue Growth (YoY)
118.4%
Profit Margin
-238.6%
Share & Embed Analysis
Last updated: September 22, 2026 12:45 AM ET
Data refreshes hourly during market hours. Next update: 1:45 AM
Data refreshes hourly during market hours. Next update: 1:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AUTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$311 | 52 HOLD |
